Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
180 Life Sciences Corp (ATNF)
180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

180 Life Sciences Corp 3000 EL CAMINO REAL BUILDING 4 SUITE 200 PALO ALTO CA 94306 USA

https://180lifesciences.com P: 650-507-0669

Description:

180 Life Sciences Corp. is a clinical-stage biotechnology company. It is focused on the development of novel drugs for unmet needs in inflammatory diseases, fibrosis and pain. 180 Life Sciences Corp., formerly known as KBL Merger Corp. IV, is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 1,779
Enterprise Value, $K -5,161
Shares Outstanding, K 7,476
Annual Sales, $ 0 K
Annual Net Income, $ -38,730 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,270 K
EBIT, $ -17,660 K
EBITDA, $ 18,630 K
60-Month Beta 0.47
% of Insider Shareholders 5.90%
% of Institutional Shareholders 4.07%
Float, K 7,034
% Float 94.10%
Short Volume Ratio 0.30

Growth:

1-Year Return -95.37%
3-Year Return -99.52%
5-Year Return -99.88%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/09/23
Next Earnings Date N/A
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr 78.57%
EPS Growth vs. Prev Year 89.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 12/19/22

ATNF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -501.18%
Return-on-Assets % -236.01%
Profit Margin % 0.00%
Net Margin % N/A
Debt/Equity -0.13
Price/Sales N/A
Price/Cash Flow 0.06
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -1,321.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar